Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma
Maria Effenberger, Silvio Waschina, Christina Bronowski, et al.
Hepatology Communications (2023) Vol. 7, Iss. 7
Open Access | Times Cited: 23

Showing 23 citing articles:

What defines a healthy gut microbiome?
Matthias Van Hul, Patrice D. Cani, Camille Petitfils, et al.
Gut (2024) Vol. 73, Iss. 11, pp. 1893-1908
Closed Access | Times Cited: 43
The pathophysiology of MASLD: an immunometabolic perspective
Julian Schwärzler, Felix Grabherr, Christoph Grander, et al.
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 4, pp. 375-386
Closed Access | Times Cited: 29
Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment
Jingjing Yu, Xiaoping Chen, Xiangliang Yang, et al.
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 1006-1020
Open Access | Times Cited: 11
Altered gut microbial profile accompanied by abnormal short chain fatty acid metabolism exacerbates nonalcoholic fatty liver disease progression
Chao Yang, Jiale Wu, Ligang Yang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 9
Characterization of liver, adipose, and fecal microbiome in obese patients with MASLD: links with disease severity and metabolic dysfunction parameters
Katherine J. P. Schwenger, Julia K. Copeland, Yasaman Ghorbani, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Progress in the Study of Intratumoral Microorganisms in Hepatocellular Carcinoma
Yagang Song, Shuo Tian, Zhanzhan Li, et al.
Journal of Hepatocellular Carcinoma (2025) Vol. Volume 12, pp. 59-76
Open Access | Times Cited: 1
Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
Clinical and Molecular Hepatology (2025)
Open Access | Times Cited: 1
Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers
Maria Pallozzi, Valeria De Gaetano, Natalia Di Tommaso, et al.
Nutrients (2024) Vol. 16, Iss. 14, pp. 2372-2372
Open Access | Times Cited: 7
From Non-Alcoholic Fatty Liver Disease to Liver Cancer: Microbiota and Inflammation as Key Players
Avilene Rodríguez‐Lara, Ascensión Rueda‐Robles, María José Sáez‐Lara, et al.
Pathogens (2023) Vol. 12, Iss. 7, pp. 940-940
Open Access | Times Cited: 13
Pan-cancer atlas of tumor-resident microbiome, immunity and prognosis
Dashuang Sheng, Chuandi Jin, Kaile Yue, et al.
Cancer Letters (2024) Vol. 598, pp. 217077-217077
Open Access | Times Cited: 5
Facile Labeling of Gram-Negative Bacteria with NIR-II Fluorescent Nanoprobes for Intestinal Bacteria Imaging
Wenwen Chen, Rong Chen, Yutong Sun, et al.
ACS Omega (2025) Vol. 10, Iss. 2, pp. 2044-2050
Open Access
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies
Elisa Monti, Clara Vianello, Ilaria Leoni, et al.
Cells (2025) Vol. 14, Iss. 2, pp. 84-84
Open Access
Role of Intestinal Microbiome in Potentiating Inflammation and Predicting Outcomes in Alcohol-associated Cirrhosis
Sidsel Støy, Bernd Schnabl
Gastroenterology Clinics of North America (2025)
Closed Access
Therapeutic role of Prunella vulgaris L. polysaccharides in non-alcoholic steatohepatitis and gut dysbiosis
Mingjiang Zhu, Yijie Song, Pei-Li Rao, et al.
Journal of Integrative Medicine (2025)
Closed Access
Firmicutes/Bacteroidetes and Firmicutes/Proteobacteria ratios are associated with worse prognosis in a cohort of Latin American patients with cirrhosis
Augusto Mantovani, Larisse Longo, Rutiane Ullmann Thoen, et al.
Clinics (2024) Vol. 79, pp. 100471-100471
Open Access | Times Cited: 3
Impact of diet and gut microbiota changes in the development of hepatocellular carcinoma
Giuseppe Guido Maria Scarlata, Claudia Cicino, Rocco Spagnuolo, et al.
Hepatoma Research (2024)
Open Access | Times Cited: 3
Oral microbiome characteristics in patients with pediatric solid tumor
Xichun Cui, Xiaoran Du, Xu Cui, et al.
Frontiers in Microbiology (2024) Vol. 14
Open Access | Times Cited: 2
The intrahepatic bacterial metataxonomic signature of patients with hepatocellular carcinoma
Jie Li, Xuanpei Zhai, Changzhou Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Apelin and the gut microbiome: Potential interaction in human MASLD
Maria Effenberger, Christoph Grander, Bela Hausmann, et al.
Digestive and Liver Disease (2023) Vol. 56, Iss. 6, pp. 932-940
Closed Access | Times Cited: 2
Characteristics of gut microbiome in patients with pediatric solid tumor
Xiaoran Du, Xu Cui, Rongrong Fan, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access
Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
Chenyang Li, Chujun Cai, Chendong Wang, et al.
Clinical and Molecular Hepatology (2024)
Open Access
Exploring the diversity of blood microbiome during liver diseases: Unveiling Novel diagnostic and therapeutic Avenues
Vasudevan Dinakaran, Arulraj Ramakrishnan, Ganesan Velmurugan
Heliyon (2023) Vol. 9, Iss. 11, pp. e21662-e21662
Open Access | Times Cited: 1
Metabolom und Mikrobiom
Konrad Aden, Lina Welz
Deleted Journal (2023) Vol. 18, Iss. 6, pp. 448-454
Closed Access
Page 1

Scroll to top